Even if I accepted your assertion, (tho I could throw national state of health/quality of life into the pot to expand that debate), I'd expect existing treatments to be protected against inflation & ppn growth as a min. Even if new treatments prove unaffordable
So are such pts really surviving longer, in your opinion? Or is it possible there's an inflationary effect on life expectancy because of early diagnosis?
-
-
Sadly, that is not an issue in head & neck cancer.
-
That sounds very clear. Too many important bits hanging around in that part of the anatomy?
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.